Dr Steven Bradshaw: LEADING DRUGS INDUSTRY ACQUISITIONS EXPERT SAYS ASTRAZENECA TAKEOVER COULD BE GOOD NEWS FOR NHS

London, UK: DR STEVEN BRADSHAW URGES CRITICS TO SEE BENEFITS - TO STAKEHOLDERS, HEALTHCARE PROVIDERS AND PATIENTSIt’s the UK economy’s largest ever takeover - and one that has attracted widespread concern. But now a leading drugs industry acquisitions expert is urging politicians to see the benefits of the AstraZeneca/Pfizer merger Dr Steven Bradshaw, who advises major pharmaceutical companies on drug pricing, market access and portfolio evaluations, says the takeover could be a good thing for Britain and the NHS. As he says: “Although the government sees this merger as being a